Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer (Q80282002)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486065%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486065%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

Bostner J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486065%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ahnström Waltersson M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486065%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Fornander T

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486065%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Skoog L

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486065%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Nordenskjöld B

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486065%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Stål O

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486065%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

7 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486065%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486065%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486065%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486065%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

6997-7005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486065%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210506

30 December 2019

exact match

0 references

cites work

Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Gene amplification in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Endocrine-responsive breast cancer and strategies for combating resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Prognostic relevance of gene amplifications and coamplifications in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

p21-activated Kinase-1 Signaling Mediates Cyclin D1 Expression in Mammary Epithelial and Cancer Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

11q13 amplification in local recurrence of human primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Minireview: Cyclin D1: normal and abnormal functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Pak up your breast tumor--and grow!

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Patterns of dna amplification at band q13 of chromosome 11 in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Active p21-activated kinase 1 rescues MCF10A breast epithelial cells from undergoing anoikis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Cyclin D1, EMS1 and 11q13 amplification in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Nuclear p21-activated kinase 1 in breast cancer packs off tamoxifen sensitivity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among 'high risk' pre- and postmenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Nuclear localization and chromatin targets of p21-activated kinase 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Regulatable Expression of p21-activated Kinase-1 Promotes Anchorage-independent Growth and Abnormal Organization of Mitotic Spindles in Human Epithelial Breast Cancer Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

p21-activated kinase 1 regulates microtubule dynamics by phosphorylating tubulin cofactor B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

PAK1 hyperactivation is sufficient for mammary gland tumor formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021

CDK-independent activation of estrogen receptor by cyclin D1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210506

7 January 2021